These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2286463)

  • 1. Fosfomycin trometamol: activity in vitro against urinary tract pathogens.
    Greenwood D
    Infection; 1990; 18 Suppl 2():S60-4. PubMed ID: 2286463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The trometamol salt of fosfomycin: microbiological evaluation.
    Greenwood D; Coyle S; Andrew J
    Eur Urol; 1987; 13 Suppl 1():69-75. PubMed ID: 3552702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between bactericidal activity of fosfomycin trometamol in an in vitro model of the urinary bladder and susceptibility testing.
    Pinasi C; Albini E; Marca G
    Eur Urol; 1987; 13 Suppl 1():80-5. PubMed ID: 3569383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the activity of the trometamol salt of fosfomycin.
    Greenwood D; Jones A; Eley A
    Eur J Clin Microbiol; 1986 Feb; 5(1):29-34. PubMed ID: 3084242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fosfomycin trometamol: multiple-dose regimen for the treatment of lower urinary tract infections].
    Sádaba-Díaz de Rada B; Azanza-Perea JR; García-Quetglas E; Honorato-Pérez J
    Enferm Infecc Microbiol Clin; 2006 Nov; 24(9):546-50. PubMed ID: 17125672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of the trometamol salt of fosfomycin in an in vitro model of the treatment of bacterial cystitis.
    Greenwood D
    Infection; 1986; 14(4):186-9. PubMed ID: 3531023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected Activity of Oral Fosfomycin against Resistant Strains of Escherichia coli in Murine Pyelonephritis.
    Pourbaix A; Guérin F; Burdet C; Massias L; Chau F; Cattoir V; Fantin B
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31160291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of fosmidomycin in an in vitro model of the treatment of bacterial cystitis.
    Kanimoto Y; Greenwood D
    Infection; 1987; 15(6):465-8. PubMed ID: 3325431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of Monuril in lower urinary tract infections due to fosfomycin-resistant bacteria.
    Neuman M; Rufin F
    Eur Urol; 1987; 13 Suppl 1():105-7. PubMed ID: 3552693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the response of Escherichia coli to fosfomycin and fosmidomycin.
    Kanimoto Y; Greenwood D
    Eur J Clin Microbiol; 1987 Aug; 6(4):386-91. PubMed ID: 3311734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses against
    Abbott IJ; van Gorp E; Wijma RA; Meletiadis J; Roberts JA; Mouton JW; Peleg AY
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fosfomycin trometamol: historical background and clinical development.
    Gialdroni Grassi G
    Infection; 1990; 18 Suppl 2():S57-9. PubMed ID: 2286462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria.
    Keating GM
    Drugs; 2013 Nov; 73(17):1951-66. PubMed ID: 24202878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and Pharmacodynamics of Fosfomycin and Its Activity against Extended-Spectrum-β-Lactamase-, Plasmid-Mediated AmpC-, and Carbapenemase-Producing Escherichia coli in a Murine Urinary Tract Infection Model.
    Zykov IN; Samuelsen Ø; Jakobsen L; Småbrekke L; Andersson DI; Sundsfjord A; Frimodt-Møller N
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol.
    Ungheri D; Albini E; Belluco G
    J Chemother; 2002 Jun; 14(3):237-40. PubMed ID: 12120876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why fosfomycin trometamol as first line therapy for uncomplicated UTI?
    Schito GC
    Int J Antimicrob Agents; 2003 Oct; 22 Suppl 2():79-83. PubMed ID: 14527776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities.
    Fedrigo NH; Mazucheli J; Albiero J; Shinohara DR; Lodi FG; Machado ACDS; Sy SKB; Tognim MCB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of oral fosfomycin-trometamol in patients with catheter-associated urinary tract infections (CAUTI): new indications for an old antibiotic?
    Cai T; Cocci A; Verze P; Rizzo M; Palmieri A; Liguori G; Trombetta C; Adembri C; Carini M; Bartoletti R; Wagenlehner FM; Bonkat G; Mirone V; Bjerklund Johansen TE; Novelli A
    J Chemother; 2018 Sep; 30(5):290-295. PubMed ID: 30843774
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Wenzler E; Meyer KM; Bleasdale SC; Sikka M; Mendes RE; Bunnell KL; Finnemeyer M; Rosenkranz SL; Danziger LH; Rodvold KA
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of pH, inoculum and media on the in vitro bactericidal activity of fosfomycin trometamol, norfloxacin and cotrimoxazole.
    Albini E; Belluco G; Marca G
    Chemioterapia; 1986 Aug; 5(4):268-72. PubMed ID: 3533286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.